Reference spectra from squamous epithelium and connective tissue allow whole section proteomics analysis

References

• Abrahamson M, Alvarez-Fernandez M, Nathanson CM. (2003). Cystatins. Biochem Soc Symp 70:179–99.
   PubMed Web of Science ®Google Scholar
• Ball HJ, Hunt NH. (2004). Needle in a haystack: microdissecting the proteome of a tissue. Amino Acids 27:1–7.
   PubMed Web of Science ®Google Scholar
• Bosch FX, Ritter D, Enders C, Flechtenmacher C, Abel U, Dietz A, Hergenhahn M, Weidauer H. (2004). Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value. Int J Cancer 111:530–38.
   PubMed Web of Science ®Google Scholar
• Bouamrani A, Ternier J, Ratel D, Benabid AL, Issartel JP, Brambilla E, Berger F. (2006). Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem 52:2103–6.
   PubMed Web of Science ®Google Scholar
• Braakhuis BJ, Leemans CR, Brakenhoff RH. (2005). Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 15:113–20.
   PubMed Web of Science ®Google Scholar
• Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. (1996). Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56:2488–92.
   PubMed Web of Science ®Google Scholar
• Chaurand P, Sanders ME, Jensen RA, Caprioli RM. (2004). Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol 165:1057–68.
   PubMed Web of Science ®Google Scholar
• Eisen MB, Spellman PT, Brown PO, Botstein D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863–8.
   PubMed Web of Science ®Google Scholar
• Engwegen JY, Gast MC, Schellens JH, Beijnen JH. (2006). Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 27:251–9.
   PubMed Web of Science ®Google Scholar
• Espina V, Dettloff KA, Cowherd S, Petricoin EF, 3rd Liotta, LA. (2004). Use of proteomic analysis to monitor responses to biological therapies. Expert Opin Biol Ther 4:83–93.
   PubMed Web of Science ®Google Scholar
• Jovanovic A, van der Tol IG, Schulten EA, Kostense PJ, de Vries N, Snow GB, van der Waal I. (1994). Risk of multiple primary tumors following oral squamous-cell carcinoma. Int J Cancer 56:320–3.
   PubMed Web of Science ®Google Scholar
• Lenz CF, Pfuhl A, Finckh M, Weidauer H, Bosch FX. (1998). Oral leukoplakias show numerical chromosomal aberrations detected by fluorescence in situ hybridization. Laryngoscope 108:917–22.
   PubMed Web of Science ®Google Scholar
• Mashberg A, Samit AM. (1989). Early detection, diagnosis, and management of oral and oropharyngeal cancer. CA Cancer J Clin 39:67–88.
   PubMed Web of Science ®Google Scholar
• Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Moller U, Osterloh D, Halbhuber KJ, Von Eggeling F. (2003). Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip(R) technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry. Mol Cell Proteomics 2:443–52.
   PubMed Web of Science ®Google Scholar
• Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Moller U, Osterloh D, Halbhuber KJ, von Eggeling F. (2004). A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res 64:4099–104.
   PubMed Web of Science ®Google Scholar
• Mueller MM, Fusenig NE. (2004). Friends or foes – bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–49.
   PubMed Web of Science ®Google Scholar
• Nees M, Homann N, Discher H, Andl T, Enders C, Herold-Mende C, Schuhmann A, Bosch FX. (1993). Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 53:4189–96.
   PubMed Web of Science ®Google Scholar
• Ogden GR, Chisholm DM, Morris AM, Stevenson JH. (1997). Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. J Pathol 182:180–84.
   PubMed Web of Science ®Google Scholar
• Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A’Hern RP, Langdon JD. (2000). A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 60:3893–8.
   PubMed Web of Science ®Google Scholar
• Roesch-Ely M, Nees M, Karsai S, Ruess A, Bogumil R, Warnken U, Schnolzer M, Dietz A, Plinkert PK, Hofele C, Bosch FX. (2007). Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 26:54–64.
   PubMed Web of Science ®Google Scholar
• Roesch Ely M, Nees M, Karsai S, Magele I, Bogumil R, Vorderwulbecke S, Ruess A, Dietz A, Schnolzer M, Bosch FX. (2005). Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma. Eur J Cell Biol 84:431–44.
   PubMed Web of Science ®Google Scholar
• Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, Berean K, Epstein JB, Priddy R, Le ND, Zhang L. (2000). Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 6:357–62.
   PubMed Web of Science ®Google Scholar
• Rosin MP, Lam WL, Poh C, Le ND, Li RJ, Zeng T, Priddy R, Zhang L. (2002). 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 62:6447–50.
   PubMed Web of Science ®Google Scholar
• Schwartz SA, Weil RJ, Johnson MD, Toms SA, Caprioli RM. (2004). Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10:981–7.
   PubMed Web of Science ®Google Scholar
• Slaughter DP, Southwick HW, Smejkal W. (1953). Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963–8.
   PubMed Web of Science ®Google Scholar
• Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, Snow GB, Leemans CR, Braakhuis BJ. (2001). Persistence of genetically altered fields in head and neck cancer patients:biological and clinical implications. Clin Cancer Res 7:1523–32.
   PubMed Web of Science ®Google Scholar
• Tlsty TD, Coussens LM. (2006). Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119–50.
   PubMed Web of Science ®Google Scholar
• Verma M, Wright GL, Jr., Hanash SM, Gopal-Srivastava R, Srivastava S. (2001). Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann NY Acad Sci 945:103–15.
   PubMed Web of Science ®Google Scholar
• Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, Frebourg T, Iggo R. (1997). Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene 14:163–9.
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya S. (2000). Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 190:407–9.
   PubMed Web of Science ®Google Scholar
• Wiesner A. (2004). Detection of tumor markers with ProteinChip technology. Curr Pharm Biotechnol 5:45–67.
   PubMed Web of Science ®Google Scholar
• Willhauck MJ, Mirancea N, Vosseler S, Pavesio A, Boukamp P, Mueller MM, Fusenig NE, Stark HJ. (2007). Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation. Carcinogenesis 28:595–610.
   PubMed Web of Science ®Google Scholar
• Wilson TJ, Singh RK. (2007). Proteases as modulators of tumor-stromal interaction: Primary tumors to bone metastases. Biochim Biophys Acta 1785:85–95.
   PubMed Web of Science ®Google Scholar
• Wolf C, Flechtenmacher C, Dietz A, Weidauer H, Abel U, Maier H, Bosch FX. (2004). p53-positive tumor-distant squamous epithelia of the head and neck reveal selective loss of chromosome 17. Laryngoscope 114:698–704.
   PubMed Web of Science ®Google Scholar
• Wright GL Jr. (2002). SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev Mol Diagn 2:549–63.
   PubMedGoogle Scholar